The DOI matches its Crossref record; 140 of the 140 references it cites were found in a registry or an index.
Regulation of cardiac hypertrophy by intracellular signalling pathways
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jenuwein, T., & Allis, C. D. (2001) · Science · doi:10.1126/science.1063127 · Cited by 9,756
The phosphoinositide 3-kinase pathway
Cantley, L. C. (2002) · Science · doi:10.1126/science.296.5573.1655 · Cited by 5,621
Histone deacetylases (HDACs): characterization of the classical HDAC family
RUIJTER, A. J. M. D., GENNIP, A. H. V., CARON, H. N., KEMP, S., & KUILENBURG, A. B. P. V. (2003) · Biochemical Journal · doi:10.1042/bj20021321 · Cited by 3,114
A Calcineurin-Dependent Transcriptional Pathway for Cardiac Hypertrophy
Molkentin, J. D., Lu, J.-R., Antos, C. L., Markham, B., Richardson, J., Robbins, J., Grant, S. R., & Olson, E. N. (1998) · Cell · doi:10.1016/s0092-8674(00)81573-1 · Cited by 2,566
Self-citationLong-term trends in the incidence of and survival with heart failure
Levy, D., Kenchaiah, S., Larson, M. G., Benjamin, E. J., Kupka, M. J., Ho, K. K. L., Murabito, J. M., & Vasan, R. S. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020265 · Cited by 2,152
Cho, H., Mu, J., Kim, J. K., Thorvaldsen, J. L., Chu, Q., Crenshaw, E. B., Kaestner, K. H., Bartolomei, M. S., Shulman, G. I., & Birnbaum, M. J. (2001) · Science · doi:10.1126/science.292.5522.1728 · Cited by 1,836
Organization and regulation of mitogen-activated protein kinase signaling pathways
Garrington, T. P., & Johnson, G. L. (1999) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(99)80028-3 · Cited by 1,275
Class II Histone Deacetylases Act as Signal-Responsive Repressors of Cardiac Hypertrophy
Zhang, C. L., McKinsey, T. A., Chang, S., Antos, C. L., Hill, J. A., & Olson, E. N. (2002) · Cell · doi:10.1016/s0092-8674(02)00861-9 · Cited by 973
Cho, H., Thorvaldsen, J. L., Chu, Q., Feng, F., & Birnbaum, M. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100462200 · Cited by 959
Shiojima, I. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24682 · Cited by 939
Seven-transmembrane-spanning receptors and heart function
Rockman, H. A., Koch, W. J., & Lefkowitz, R. J. (2002) · Nature · doi:10.1038/415206a · Cited by 938
Growth retardation and increased apoptosis in mice with homozygous disruption of the akt1 gene
Chen, W. S., Xu, P.-Z., Gottlob, K., Chen, M.-L., Sokol, K., Shiyanova, T., Roninson, I., Weng, W., Suzuki, R., Tobe, K., et al. (2001) · Genes & Development · doi:10.1101/gad.913901 · Cited by 928
Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy
Takimoto, E., Champion, H. C., Li, M., Belardi, D., Ren, S., Rodriguez, E. R., Bedja, D., Gabrielson, K. L., Wang, Y., & Kass, D. A. (2005) · Nature Medicine · doi:10.1038/nm1175 · Cited by 903
ErbB2 is essential in the prevention of dilated cardiomyopathy
Crone, S. A., Zhao, Y.-Y., Fan, L., Gu, Y., Minamisawa, S., Liu, Y., Peterson, K. L., Chen, J., Kahn, R., Condorelli, G., et al. (2002) · Nature Medicine · doi:10.1038/nm0502-459 · Cited by 903
The Zinc Finger-containing Transcription Factors GATA-4, -5, and -6
Molkentin, J. D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.r000029200 · Cited by 880
Self-citationArber, S., Hunter, J. J., Ross, J., Hongo, M., Sansig, G., Borg, J., Perriard, J.-C., Chien, K. R., & Caroni, P. (1997) · Cell · doi:10.1016/s0092-8674(00)81878-4 · Cited by 838
Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death
Haider, A. W., Larson, M. G., Benjamin, E. J., & Levy, D. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00407-0 · Cited by 800
Knöll, R., Hoshijima, M., Hoffman, H. M., Person, V., Lorenzen-Schmidt, I., Bang, M.-L., Hayashi, T., Shiga, N., Yasukawa, H., Schaper, W., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)01226-6 · Cited by 786
The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice
Bueno, O. F. (2000) · The EMBO Journal · doi:10.1093/emboj/19.23.6341 · Cited by 774
Calcineurin/NFAT Coupling Participates in Pathological, but not Physiological, Cardiac Hypertrophy
Wilkins, B. J., Dai, Y.-S., Bueno, O. F., Parsons, S. A., Xu, J., Plank, D. M., Jones, F., Kimball, T. R., & Molkentin, J. D. (2004) · Circulation Research · doi:10.1161/01.res.0000109415.17511.18 · Cited by 761
Self-citationPende, M., Um, S. H., Mieulet, V., Sticker, M., Goss, V. L., Mestan, J., Mueller, M., Fumagalli, S., Kozma, S. C., & Thomas, G. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.8.3112-3124.2004 · Cited by 742
Asakura, M., Kitakaze, M., Takashima, S., Liao, Y., Ishikura, F., Yoshinaka, T., Ohmoto, H., Node, K., Yoshino, K., Ishiguro, H., et al. (2002) · Nature Medicine · doi:10.1038/nm0102-35 · Cited by 724
Drosophila S6 Kinase: A Regulator of Cell Size
Montagne, J., Stewart, M. J., Stocker, H., Hafen, E., Kozma, S. C., & Thomas, G. (1999) · Science · doi:10.1126/science.285.5436.2126 · Cited by 717
Cytoplasmic Signaling Pathways That Regulate Cardiac Hypertrophy
Molkentin, J. D., & Dorn II, G. W. (2001) · Annual Review of Physiology · doi:10.1146/annurev.physiol.63.1.391 · Cited by 689
Self-citationMechanical stress activates angiotensin II type 1 receptor without the involvement of angiotensin II
Zou, Y., Akazawa, H., Qin, Y., Sano, M., Takano, H., Minamino, T., Makita, N., Iwanaga, K., Zhu, W., Kudoh, S., et al. (2004) · Nature Cell Biology · doi:10.1038/ncb1137 · Cited by 683
Class II histone deacetylases: versatile regulators
Verdin, E., Dequiedt, F., & Kasler, H. G. (2003) · Trends in Genetics · doi:10.1016/s0168-9525(03)00073-8 · Cited by 664
The Beginning of the End: IκB Kinase (IKK) and NF-κB Activation
Karin, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.39.27339 · Cited by 640
Protein kinase cascades in the regulation of cardiac hypertrophy
Dorn, G. W., & Force, T. L. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200524178 · Cited by 638
Disruption of the p70s6k/p85s6k gene reveals a small mouse phenotype and a new functional S6 kinase
Shima, H. (1998) · The EMBO Journal · doi:10.1093/emboj/17.22.6649 · Cited by 636
Transgenic Gαq overexpression induces cardiac contractile failure in mice
D’Angelo, D. D., Sakata, Y., Lorenz, J. N., Boivin, G. P., Walsh, R. A., Liggett, S. B., & Dorn, G. W. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.15.8121 · Cited by 629
Chang, S., McKinsey, T. A., Zhang, C. L., Richardson, J. A., Hill, J. A., & Olson, E. N. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.19.8467-8476.2004 · Cited by 613
The conserved phosphoinositide 3-kinase pathway determines heart size in mice
Shioi, T. (2000) · The EMBO Journal · doi:10.1093/emboj/19.11.2537 · Cited by 604
Calmodulin kinase II inhibition protects against structural heart disease
Zhang, R., Khoo, M. S. C., Wu, Y., Yang, Y., Grueter, C. E., Ni, G., Price, E. E., Thiel, W., Guatimosim, S., Song, L.-S., et al. (2005) · Nature Medicine · doi:10.1038/nm1215 · Cited by 579
Regulation of Myocardial Contractility and Cell Size by Distinct PI3K-PTEN Signaling Pathways
Crackower, M. A., Oudit, G. Y., Kozieradzki, I., Sarao, R., Sun, H., Sasaki, T., Hirsch, E., Suzuki, A., Shioi, T., Irie-Sasaki, J., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)00969-8 · Cited by 576
Zhang, T., Maier, L. S., Dalton, N. D., Miyamoto, S., Ross, J., Bers, D. M., & Brown, J. H. (2003) · Circulation Research · doi:10.1161/01.res.0000069686.31472.c5 · Cited by 556
HDAC4 deacetylase associates with and represses the MEF2 transcription factor
Miska, E. A. (1999) · The EMBO Journal · doi:10.1093/emboj/18.18.5099 · Cited by 555
Akt1 Is Required for Physiological Cardiac Growth
DeBosch, B., Treskov, I., Lupu, T. S., Weinheimer, C., Kovacs, A., Courtois, M., & Muslin, A. J. (2006) · Circulation · doi:10.1161/circulationaha.105.595231 · Cited by 535
McMullen, J. R., Shioi, T., Zhang, L., Tarnavski, O., Sherwood, M. C., Kang, P. M., & Izumo, S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1934654100 · Cited by 534
Enhanced Gαq signaling: A common pathway mediates cardiac hypertrophy and apoptotic heart failure
Adams, J. W., Sakata, Y., Davis, M. G., Sah, V. P., Wang, Y., Liggett, S. B., Chien, K. R., Brown, J. H., & Dorn, G. W. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.17.10140 · Cited by 525
CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo
Passier, R., Zeng, H., Frey, N., Naya, F. J., Nicol, R. L., McKinsey, T. A., Overbeek, P., Richardson, J. A., Grant, S. R., & Olson, E. N. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8551 · Cited by 521
Lu, J., McKinsey, T. A., Nicol, R. L., & Olson, E. N. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.080064097 · Cited by 518
McMullen, J. R., Sherwood, M. C., Tarnavski, O., Zhang, L., Dorfman, A. L., Shioi, T., & Izumo, S. (2004) · Circulation · doi:10.1161/01.cir.0000130641.08705.45 · Cited by 518
Sugden, P. H., & Clerk, A. (1998) · Circulation Research · doi:10.1161/01.res.83.4.345 · Cited by 513
Vega, R. B., Harrison, B. C., Meadows, E., Roberts, C. R., Papst, P. J., Olson, E. N., & McKinsey, T. A. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.19.8374-8385.2004 · Cited by 511
Akt/Protein Kinase B Promotes Organ Growth in Transgenic Mice
Shioi, T., McMullen, J. R., Kang, P. M., Douglas, P. S., Obata, T., Franke, T. F., Cantley, L. C., & Izumo, S. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.8.2799-2809.2002 · Cited by 506
MOLKENTIN, J. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.01.021 · Cited by 497
Self-citationHospitalization of patients with heart failure: National Hospital Discharge Survey, 1985 to 1995
Haldeman, G. A., Croft, J. B., Giles, W. H., & Rashidee, A. (1999) · American Heart Journal · doi:10.1053/hj.1999.v137.95495 · Cited by 490
Wu, X. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27374 · Cited by 478
Activated glycogen synthase-3β suppresses cardiac hypertrophy in vivo
Antos, C. L., McKinsey, T. A., Frey, N., Kutschke, W., McAnally, J., Shelton, J. M., Richardson, J. A., Hill, J. A., & Olson, E. N. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.231619298 · Cited by 477
Conditional mutation of the ErbB2 (HER2) receptor in cardiomyocytes leads to dilated cardiomyopathy
Özcelik, C., Erdmann, B., Pilz, B., Wettschureck, N., Britsch, S., Hübner, N., Chien, K. R., Birchmeier, C., & Garratt, A. N. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122249299 · Cited by 473
The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease
OUDIT, G. (2004) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2004.05.015 · Cited by 469
Patrucco, E., Notte, A., Barberis, L., Selvetella, G., Maffei, A., Brancaccio, M., Marengo, S., Russo, G., Azzolino, O., Rybalkin, S. D., et al. (2004) · Cell · doi:10.1016/j.cell.2004.07.017 · Cited by 468
Gschwind, A., Zwick, E., Prenzel, N., Leserer, M., & Ullrich, A. (2001) · Oncogene · doi:10.1038/sj.onc.1204192 · Cited by 462
Rapamycin Attenuates Load-Induced Cardiac Hypertrophy in Mice
Shioi, T., McMullen, J. R., Tarnavski, O., Converso, K., Sherwood, M. C., Manning, W. J., & Izumo, S. (2003) · Circulation · doi:10.1161/01.cir.0000057979.36322.88 · Cited by 462
Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice
Condorelli, G., Drusco, A., Stassi, G., Bellacosa, A., Roncarati, R., Iaccarino, G., Russo, M. A., Gu, Y., Dalton, N., Chung, C., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172376399 · Cited by 461
Targeting the Receptor-G q Interface to Inhibit in Vivo Pressure Overload Myocardial Hypertrophy
Akhter, S. A., Luttrell, L. M., Rockman, H. A., Iaccarino, G., Lefkowitz, R. J., & Koch, W. J. (1998) · Science · doi:10.1126/science.280.5363.574 · Cited by 452
Ross, R. S., & Borg, T. K. (2001) · Circulation Research · doi:10.1161/hh1101.091862 · Cited by 451
Calcium–calcineurin signaling in the regulation of cardiac hypertrophy
Wilkins, B. J., & Molkentin, J. D. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.07.121 · Cited by 440
Self-citationControl of Cardiac Growth by Histone Acetylation/Deacetylation
Backs, J., & Olson, E. N. (2006) · Circulation Research · doi:10.1161/01.res.0000197782.21444.8f · Cited by 440
Phenotypic Spectrum Caused by Transgenic Overexpression of Activated Akt in the Heart
Matsui, T., Li, L., Wu, J. C., Cook, S. A., Nagoshi, T., Picard, M. H., Liao, R., & Rosenzweig, A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200347200 · Cited by 434
Li, H.-H., Kedar, V., Zhang, C., McDonough, H., Arya, R., Wang, D.-Z., & Patterson, C. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422220 · Cited by 430
Oka, T., Maillet, M., Watt, A. J., Schwartz, R. J., Aronow, B. J., Duncan, S. A., & Molkentin, J. D. (2006) · Circulation Research · doi:10.1161/01.res.0000215985.18538.c4 · Cited by 423
Self-citationRoles of Cardiac Transcription Factors in Cardiac Hypertrophy
Akazawa, H., & Komuro, I. (2003) · Circulation Research · doi:10.1161/01.res.0000072977.86706.23 · Cited by 406
Sizing up the heart: development redux in disease
Olson, E. N., & Schneider, M. D. (2003) · Genes & Development · doi:10.1101/gad.1110103 · Cited by 385
Suppression of Class I and II Histone Deacetylases Blunts Pressure-Overload Cardiac Hypertrophy
Kong, Y., Tannous, P., Lu, G., Berenji, K., Rothermel, B. A., Olson, E. N., & Hill, J. A. (2006) · Circulation · doi:10.1161/circulationaha.106.625467 · Cited by 377
Esposito, G., Rapacciuolo, A., Naga Prasad, S. V., Takaoka, H., Thomas, S. A., Koch, W. J., & Rockman, H. A. (2002) · Circulation · doi:10.1161/hc0102.101365 · Cited by 377
Wettschureck, N., Rütten, H., Zywietz, A., Gehring, D., Wilkie, T. M., Chen, J., Chien, K. R., & Offermanns, S. (2001) · Nature Medicine · doi:10.1038/nm1101-1236 · Cited by 373
Kee, H. J., Sohn, I. S., Nam, K. I., Park, J. E., Qian, Y. R., Yin, Z., Ahn, Y., Jeong, M. H., Bang, Y.-J., Kim, N., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.559724 · Cited by 368
The Transcription Factors GATA4 and GATA6 Regulate Cardiomyocyte Hypertrophy in Vitro and in Vivo
Liang, Q., De Windt, L. J., Witt, S. A., Kimball, T. R., Markham, B. E., & Molkentin, J. D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102174200 · Cited by 363
Self-citationZhang, D., Gaussin, V., Taffet, G. E., Belaguli, N. S., Yamada, M., Schwartz, R. J., Michael, L. H., Overbeek, P. A., & Schneider, M. D. (2000) · Nature Medicine · doi:10.1038/75037 · Cited by 337
The in vivo role of p38 MAP kinases in cardiac remodeling and restrictive cardiomyopathy
Liao, P., Georgakopoulos, D., Kovacs, A., Zheng, M., Lerner, D., Pu, H., Saffitz, J., Chien, K., Xiao, R.-P., Kass, D. A., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211086598 · Cited by 333
Braz, J. C., Bueno, O. F., Liang, Q., Wilkins, B. J., Dai, Y.-S., Parsons, S., Braunwart, J., Glascock, B. J., Klevitsky, R., Kimball, T. F., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17295 · Cited by 332
Self-citationHunter, J. J., Tanaka, N., Rockman, H. A., Ross, J., & Chien, K. R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.39.23173 · Cited by 312
Calsarcins, a novel family of sarcomeric calcineurin-binding proteins
Frey, N., Richardson, J. A., & Olson, E. N. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.260501097 · Cited by 302
Brancaccio, M., Fratta, L., Notte, A., Hirsch, E., Poulet, R., Guazzone, S., De Acetis, M., Vecchione, C., Marino, G., Altruda, F., et al. (2003) · Nature Medicine · doi:10.1038/nm805 · Cited by 296
Zannad, F., Briancon, S., Juilliere, Y., Mertes, P.-M., Villemot, J.-P., Alla, F., & Virion, J.-M. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00634-2 · Cited by 295
Myocyte-enriched calcineurin-interacting protein, MCIP1, inhibits cardiac hypertrophy in vivo
Rothermel, B. A., McKinsey, T. A., Vega, R. B., Nicol, R. L., Mammen, P., Yang, J., Antos, C. L., Shelton, J. M., Bassel-Duby, R., Olson, E. N., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.041614798 · Cited by 294
Activated MEK5 induces serial assembly of sarcomeres and eccentric cardiac hypertrophy
Nicol, R. L. (2001) · The EMBO Journal · doi:10.1093/emboj/20.11.2757 · Cited by 281
Shai, S.-Y., Harpf, A. E., Babbitt, C. J., Jordan, M. C., Fishbein, M. C., Chen, J., Omura, M., Leil, T. A., Becker, K. D., Jiang, M., et al. (2002) · Circulation Research · doi:10.1161/hh0402.105790 · Cited by 281
Yamamoto, S., Yang, G., Zablocki, D., Liu, J., Hong, C., Kim, S.-J., Soler, S., Odashima, M., Thaisz, J., Yehia, G., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17459 · Cited by 278
Fiedler, B., Lohmann, S. M., Smolenski, A., Linnemüller, S., Pieske, B., Schröder, F., Molkentin, J. D., Drexler, H., & Wollert, K. C. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162100799 · Cited by 276
Self-citationWilkins, B. J., De Windt, L. J., Bueno, O. F., Braz, J. C., Glascock, B. J., Kimball, T. F., & Molkentin, J. D. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.21.7603-7613.2002 · Cited by 262
Self-citationMende, U., Kagen, A., Cohen, A., Aramburu, J., Schoen, F. J., & Neer, E. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13893 · Cited by 258
Reengineering Inducible Cardiac-Specific Transgenesis With an Attenuated Myosin Heavy Chain Promoter
Sanbe, A., Gulick, J., Hanks, M. C., Liang, Q., Osinska, H., & Robbins, J. (2003) · Circulation Research · doi:10.1161/01.res.0000065442.64694.9f · Cited by 249
Nishida, K., Yamaguchi, O., Hirotani, S., Hikoso, S., Higuchi, Y., Watanabe, T., Takeda, T., Osuka, S., Morita, T., Kondoh, G., et al. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.24.10611-10620.2004 · Cited by 238
Impaired cardiac hypertrophic response in Calcineurin Aβ -deficient mice
Bueno, O. F., Wilkins, B. J., Tymitz, K. M., Glascock, B. J., Kimball, T. F., Lorenz, J. N., & Molkentin, J. D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.072647999 · Cited by 237
Self-citationSano, M., Abdellatif, M., Oh, H., Xie, M., Bagella, L., Giordano, A., Michael, L. H., DeMayo, F. J., & Schneider, M. D. (2002) · Nature Medicine · doi:10.1038/nm778 · Cited by 236
Frey, N., Barrientos, T., Shelton, J. M., Frank, D., Rütten, H., Gehring, D., Kuhn, C., Lutz, M., Rothermel, B., Bassel-Duby, R., et al. (2004) · Nature Medicine · doi:10.1038/nm1132 · Cited by 223
Does load-induced ventricular hypertrophy progress to systolic heart failure?
Berenji, K., Drazner, M. H., Rothermel, B. A., & Hill, J. A. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01303.2004 · Cited by 217
The role of the Grb2–p38 MAPK signaling pathway in cardiac hypertrophy and fibrosis
Zhang, S., Weinheimer, C., Courtois, M., Kovacs, A., Zhang, C. E., Cheng, A. M., Wang, Y., & Muslin, A. J. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16290 · Cited by 213
Nuclear Targeting of Akt Enhances Kinase Activity and Survival of Cardiomyocytes
Shiraishi, I., Melendez, J., Ahn, Y., Skavdahl, M., Murphy, E., Welch, S., Schaefer, E., Walsh, K., Rosenzweig, A., Torella, D., et al. (2004) · Circulation Research · doi:10.1161/01.res.0000124394.01180.be · Cited by 212
Targeted inhibition of calcineurin attenuates cardiac hypertrophy in vivo
De Windt, L. J., Lim, H. W., Bueno, O. F., Liang, Q., Delling, U., Braz, J. C., Glascock, B. J., Kimball, T. F., del Monte, F., Hajjar, R. J., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.031371998 · Cited by 202
Self-citationClass IA Phosphoinositide 3-Kinase Regulates Heart Size and Physiological Cardiac Hypertrophy
Luo, J., McMullen, J. R., Sobkiw, C. L., Zhang, L., Dorfman, A. L., Sherwood, M. C., Logsdon, M. N., Horner, J. W., DePinho, R. A., Izumo, S., et al. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.21.9491-9502.2005 · Cited by 198
RGS4 causes increased mortality and reduced cardiac hypertrophy in response to pressure overload
Rogers, J. H., Tamirisa, P., Kovacs, A., Weinheimer, C., Courtois, M., Blumer, K. J., Kelly, D. P., & Muslin, A. J. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6713 · Cited by 197
Liang, Q. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg474 · Cited by 197
Ras, PI3-kinase and mTOR signaling in cardiac hypertrophy
PROUD, C. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.02.003 · Cited by 197
MEF‐2 function is modified by a novel co‐repressor, MITR
Sparrow, D. B., Miska, E. A., Langley, E., Reynaud‐Deonauth, S., Kotecha, S., Towers, N., Spohr, G., Kouzarides, T., & Mohun, T. J. (1999) · The EMBO Journal · doi:10.1093/emboj/18.18.5085 · Cited by 196
Myocyte Enhancer Factors 2A and 2C Induce Dilated Cardiomyopathy in Transgenic Mice
Xu, J., Gong, N. L., Bodi, I., Aronow, B. J., Backx, P. H., & Molkentin, J. D. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510217200 · Cited by 190
Self-citationDESCHAMPS, A., & SPINALE, F. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.10.004 · Cited by 189
The roles of GATA-4, -5 and -6 in vertebrate heart development
Peterkin, T., Gibson, A., Loose, M., & Patient, R. (2005) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2004.10.003 · Cited by 180
Song, K., Backs, J., McAnally, J., Qi, X., Gerard, R. D., Richardson, J. A., Hill, J. A., Bassel-Duby, R., & Olson, E. N. (2006) · Cell · doi:10.1016/j.cell.2006.02.048 · Cited by 178
Harris, I. S., Zhang, S., Treskov, I., Kovacs, A., Weinheimer, C., & Muslin, A. J. (2004) · Circulation · doi:10.1161/01.cir.0000138190.50127.6a · Cited by 177
Freund, C., Schmidt-Ullrich, R., Baurand, A., Dunger, S., Schneider, W., Loser, P., El-Jamali, A., Dietz, R., Scheidereit, C., & Bergmann, M. W. (2005) · Circulation · doi:10.1161/01.cir.0000164237.58200.5a · Cited by 175
Lips, D. (2003) · European Heart Journal · doi:10.1016/s0195-668x(02)00829-1 · Cited by 172
Parlakian, A., Charvet, C., Escoubet, B., Mericskay, M., Molkentin, J. D., Gary-Bobo, G., De Windt, L. J., Ludosky, M.-A., Paulin, D., Daegelen, D., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.533778 · Cited by 172
Self-citationNF-κB activation is required for the development of cardiac hypertrophy in vivo
Li, Y., Ha, T., Gao, X., Kelley, J., Williams, D. L., Browder, I. W., Kao, R. L., & Li, C. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00124.2004 · Cited by 170
Peng, X. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24497 · Cited by 166
Heineke, J., Ruetten, H., Willenbockel, C., Gross, S. C., Naguib, M., Schaefer, A., Kempf, T., Hilfiker-Kleiner, D., Caroni, P., Kraft, T., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405488102 · Cited by 165
Self-citationSanna, B., Bueno, O. F., Dai, Y.-S., Wilkins, B. J., & Molkentin, J. D. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.3.865-878.2005 · Cited by 162
Self-citationApoptosis in heart: basic mechanisms and implications in cardiovascular diseases
Kang, P. M., & Izumo, S. (2003) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(03)00025-x · Cited by 150
Cardiomyopathy in transgenic mice with cardiac-specific overexpression of serum response factor
Zhang, X., Azhar, G., Chai, J., Sheridan, P. L., Nagano, K., Brown, T., Yang, J., Khrapko, K., Borras, A. M., Lawitts, J. A., et al. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.280.4.h1782 · Cited by 147
Hindley, A. D., & Kölch, W. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.8.1575 · Cited by 147
c-Jun N-Terminal Kinase Activation Mediates Downregulation of Connexin43 in Cardiomyocytes
Petrich, B. G., Gong, X., Lerner, D. L., Wang, X., Brown, J. H., Saffitz, J. E., & Wang, Y. (2002) · Circulation Research · doi:10.1161/01.res.0000035854.11082.01 · Cited by 141
Second nature: Biological functions of the Raf‐1 “kinase”
Baccarini, M. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.03.024 · Cited by 136
Wollert, K. C., Fiedler, B., Gambaryan, S. P., Smolenski, A., Heineke, J., Butt, E., Trautwein, C., Lohmann, S. M., & Drexler, H. (2002) · Hypertension · doi:10.1161/hy1201.097292 · Cited by 135
Self-citationNuclear Targeting of Akt Enhances Ventricular Function and Myocyte Contractility
Rota, M., Boni, A., Urbanek, K., Padín-Iruegas, E., Kajstura, T. J., Fiore, G., Kubo, H., Sonnenblick, E. H., Musso, E., Houser, S. R., et al. (2005) · Circulation Research · doi:10.1161/01.res.0000196568.11624.ae · Cited by 133
McMullen, J., Shioi, T., Zhang, L., Tarnavski, O., Sherwood, M., Dorfman, A., Longnus, S., Pende, M., Martin, K., Blenis, J., et al. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.14.6231-6240.2004 · Cited by 133
Zou, Y., Hiroi, Y., Uozumi, H., Takimoto, E., Toko, H., Zhu, W., Kudoh, S., Mizukami, M., Shimoyama, M., Shibasaki, F., et al. (2001) · Circulation · doi:10.1161/01.cir.104.1.97 · Cited by 131
Klein, L., O’Connor, C. M., Gattis, W. A., Zampino, M., Luca, L. D., Vitarelli, A., Fedele, F., & Gheorghiade, M. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)03336-2 · Cited by 130
Modulatory calcineurin-interacting proteins 1 and 2 function as calcineurin facilitators in vivo
Sanna, B., Brandt, E. B., Kaiser, R. A., Pfluger, P. T., Witt, S. A., Kimball, T. R., van Rooij, E., Windt, L. J. D., Rothenberg, M. E., Tschöp, M. H., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509340103 · Cited by 127
Self-citationVital epidemiologic clues in heart failure
Kannel, W. B. (2000) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(99)00135-3 · Cited by 124
Clerk, A., & Sugden, P. H. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00261-1 · Cited by 121
Kaiser, R. A., Liang, Q., Bueno, O. F., Huang, Y., Lackey, T., Klevitsky, R., Hewett, T. E., & Molkentin, J. D. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500684200 · Cited by 120
Self-citationTargeted Inhibition of Calcineurin in Pressure-overload Cardiac Hypertrophy
Hill, J. A., Rothermel, B. A., Yoo, K., Cabuay, B. M., Demetroulis, E., Weiss, R. M., Kutschke, W. J., Bassel‐Duby, R., & Williams, R. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110722200 · Cited by 119
The transcriptional repressor Nab1 is a specific regulator of pathological cardiac hypertrophy
Buitrago, M. A. B., Lorenz, K., Maass, A. H., Oberdorf‐Maass, S. U., Keller, U., Schmitteckert, E. M., Ivashchenko, Y., Lohse, M. J., & Engelhardt, S. H. (2005) · Nature Medicine · doi:10.1038/nm1272 · Cited by 116
Regulation of MEF2 by p38 MAPK and Its Implication in Cardiomyocyte Biology
Han, J., & Molkentin, J. D. (2000) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(00)00039-6 · Cited by 114
Self-citationErbB2 Pathways in Heart and Neural Diseases
Garratt, A. N. (2003) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(02)00231-1 · Cited by 112
Calcineurin and hypertrophic heart disease: novel insights and remaining questions
Bueno, O. F., van Rooij, E., Molkentin, J. D., Doevendans, P. A., & Windt, L. J. D. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00493-x · Cited by 112
Self-citationRole of histone deacetylase inhibitors in the treatment of cancer (Review)
Mei, S., Ho, A. D., & Mahlknecht, U. (2004) · International Journal of Oncology · doi:10.3892/ijo.25.6.1509 · Cited by 109
Dichotomy of Ca2+ in the heart: contraction versus intracellular signaling
Molkentin, J. D. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27824 · Cited by 100
Self-citationKAWANO, S., KUBOTA, T., Monden, Y., Kawamura, N., Tsutsui, H., Takeshita, A., & Sunagawa, K. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.04.030 · Cited by 96
Deletion of cytosolic phospholipase A2 promotes striated muscle growth
Haq, S., Kilter, H., Michael, A., Tao, J., O’Leary, E., Sun, X. M., Walters, B. M., Bhattacharya, K., Chen, X., Cui, L., et al. (2003) · Nature Medicine · doi:10.1038/nm891 · Cited by 89
Self-citationPetrich, B. G., Molkentin, J. D., & Wang, Y. (2003) · The FASEB Journal · doi:10.1096/fj.02-0438fje · Cited by 84
Self-citationBueno, O. F., Lips, D. J., Kaiser, R. A., Wilkins, B. J., Dai, Y., Glascock, B. J., Klevitsky, R., Hewett, T. E., Kimball, T. R., Aronow, B. J., et al. (2003) · Circulation Research · doi:10.1161/01.res.0000107197.99679.77 · Cited by 82
Self-citationCzubryt, M. P., & Olson Eric, N. (2004) · Recent Progress in Hormone Research · doi:10.1210/rp.59.1.105 · Cited by 70
Divergent Signaling Pathways Converge on GATA4 to Regulate Cardiac Hypertrophic Gene Expression
Liang, Q., & Molkentin, J. D. (2002) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2002.2011 · Cited by 69
Self-citationJNK1 is required to preserve cardiac function in the early response to pressure overload
Tachibana, H., Perrino, C., Takaoka, H., Davis, R. J., Prasad, S. V. N., & Rockman, H. A. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.03.065 · Cited by 66
Cyclin-Dependent Kinase-9: An RNAPII Kinase at the Nexus of Cardiac Growth and Death Cascades
Sano, M., & Schneider, M. D. (2004) · Circulation Research · doi:10.1161/01.res.0000146675.88354.04 · Cited by 54
A Transgenic Mouse Model of Heart Failure Using Inducible Gαq
Fan, G., Jiang, Y., Lu, Z., Martin, D. W., Kelly, D. J., Zuckerman, J. M., Ballou, L. M., Cohen, I. S., & Lin, R. Z. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506810200 · Cited by 52
Guidelines for the Diagnosis and Management of Heart Failure
Hobbs, R. E. (2004) · American Journal of Therapeutics · doi:10.1097/01.mjt.0000127150.21184.01 · Cited by 20
Cited by
FGF23 induces left ventricular hypertrophy
Faul, C., Amaral, A. P., Oskouei, B., Hu, M.-C., Sloan, A., Isakova, T., Gutiérrez, O. M., Aguillon-Prada, R., Lincoln, J., Hare, J. M., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci46122 · Cited by 2,027
Transient Receptor Potential Cation Channels in Disease
Nilius, B., Owsianik, G., Voets, T., & Peters, J. A. (2007) · Physiological Reviews · doi:10.1152/physrev.00021.2006 · Cited by 1,399
Jaalouk, D. E., & Lammerding, J. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2597 · Cited by 1,396
Hill, J. A., & Olson, E. N. (2008) · New England Journal of Medicine · doi:10.1056/nejmra072139 · Cited by 1,065
Sundaresan, N. R., Gupta, M., Kim, G., Rajamohan, S. B., Isbatan, A., & Gupta, M. P. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39162 · Cited by 995
Metadata
- Authors
- Heineke, J., & Molkentin, J. D.
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2006-08
- Volume
- 7
- Issue
- 8
- Pages
- 589-600
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- OpenAlex
- W2036272929
- Cited by
- 1,866
- References
- 140
- FWCI
- 10.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.